BlueCrest Capital Management’s Colgate-Palmolive CL Stock Holding History

BlueCrest Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,392	Closed	-$781K	–	520
2019 Q1	$781K	Buy	11,392 +6,623	+139%	+$428K	0.03%	353
2018 Q4	$284K	Sell	4,769 -6,475	-58%	-$405K	0.01%	531
2018 Q3	$753K	Sell	11,244 -19,714	-64%	-$1.31M	0.02%	565
2018 Q2	$2.01M	Buy	30,958 +26,636	+616%	+$1.74M	0.05%	317
2018 Q1	$310K	Buy	+4,322	New	+$311K	0.01%	1032
2017 Q3	–	Sell	-23,995	Closed	-$1.78M	–	874
2017 Q2	$1.78M	Buy	+23,995	New	+$1.78M	0.07%	354
2017 Q1	–	Sell	-4,000	Closed	-$262K	–	765
2016 Q4	$262K	Buy	+4,000	New	+$274K	0.01%	568
2015 Q4	–	Sell	-6,516	Closed	-$414K	–	996
2015 Q3	$414K	Buy	6,516 +1,443	+28%	+$94.3K	0.01%	638
2015 Q2	$332K	Buy	+5,073	New	+$344K	0.01%	692
2014 Q4	–	Sell	-3,784	Closed	-$247K	–	570
2014 Q3	$247K	Buy	+3,784	New	+$250K	0.01%	465

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

BlueCrest Capital Management's CL Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Colgate-Palmolive (CL) in Q2 2019, closing a stake of 11,392 shares — an estimated $781K sold.

BlueCrest Capital Management first reported a position in CL in Q3 2014 and held it in 10 quarters. The position peaked at $2.01M in Q2 2018. 1,457 funds tracked by Wall St. Rank hold CL as of Q2 2019.

BlueCrest Capital Management reported no remaining Colgate-Palmolive position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 11,392 Colgate-Palmolive shares in Q2 2019, an estimated $781K.
BlueCrest Capital Management first reported a position in Colgate-Palmolive in Q3 2014 and held it in 10 quarters.
BlueCrest Capital Management's Colgate-Palmolive position peaked at $2.01M in Q2 2018.
1,457 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.